House GOP blocks Trump-supported drug pricing provision from spending bill

House GOP blocks Trump-supported drug pricing provision from spending bill
© Getty

House Republicans on Thursday blocked a drug pricing amendment supported by President TrumpDonald John TrumpMost Americans break with Trump on Ukraine, but just 45 percent think he should be removed: poll Judge orders Democrats to give notice if they request Trump's NY tax returns Trump's doctor issues letter addressing 'speculation' about visit to Walter Reed MORE from inclusion in a health-care spending bill.

The provision, which passed the Senate on a bipartisan basis last month, would require drug prices to be disclosed in television advertisements for drugs in an effort to increase transparency and bring down prices.

Lawmakers and aides said that House Republicans objected to including the provision in the final version of the funding bill, which was finished by House and Senate negotiators on Thursday.

ADVERTISEMENT

Sen. Dick DurbinRichard (Dick) Joseph DurbinGOP divided over impeachment trial strategy Democratic senators introduce bill to push ICE to stop 'overuse' of solitary confinement Pentagon watchdog declines to investigate hold on Ukraine aid MORE (D-Ill.), one of the sponsors of the provision, blamed pharmaceutical companies for exercising their influence to block the measure.

“When are we going to stand up to Big Pharma?” Durbin asked.

He noted that Trump supported the measure, reading aloud a tweet from the president last month praising the measure as a move “to end the secrecy around ridiculously high drug prices.” The proposal is part of Trump’s plan to lower drug prices, something the president has been vocal about.

Republican Sen. Chuck GrassleyCharles (Chuck) Ernest GrassleySenate aides met with tax return whistleblower: report Booker, Sanders propose new federal agency to control drug prices GOP eager for report on alleged FBI surveillance abuse MORE (Iowa), who co-sponsored the measure with Durbin, tweeted Thursday that it is “EMBARRASSING to bow to BIG PHARMA at expense of consumers” and not include the provision.

Asked about the objections, Rep. Tom ColeThomas (Tom) Jeffrey ColeNew hemp trade group presses lawmakers on immigration reform, regs Bottom Line Juan Williams: Republicans flee Trump MORE (R-Okla.), the top health appropriator in the House, said he did not want to get into the details, but said that some House Republicans opposed the provision.

ADVERTISEMENT

“Our friends in the House felt differently on this topic,” said Sen. Roy BluntRoy Dean BluntMichelle Obama presents Lin-Manuel Miranda with National Portrait Award GOP divided over impeachment trial strategy Overnight Health Care: Cigarette smoking rates at new low | Spread of vaping illness slowing | Dems in Congress push to block Trump abortion rule MORE (R-Mo.), the top Senate health appropriator.

After failing to get the provision into the underlying funding bill on Thursday, Durbin offered it as an amendment before withdrawing it after other lawmakers said they did not want to jeopardize passage of the larger health funding bill by voting on the amendment.

A spokeswoman for House Energy and Commerce Committee Chairman Greg WaldenGregory (Greg) Paul WaldenHillicon Valley: Twitter shares more details on political ad rules | Supreme Court takes up Google-Oracle fight | Pentagon chief defends Microsoft cloud contract House, Senate announce agreement on anti-robocall bill House panel advances flavored e-cigarette ban MORE (R-Ore.), whose committee oversees drug pricing issues, said that he did not oppose the provision.